Medtronic plc (MDT) · Sep 17, 2026 · Other events

Medtronic corrects MiniMed exchange-offer deadline, with no change to deal terms

No new info

A procedural correction tightens the guaranteed-delivery deadline for Medtronic’s MiniMed exchange offer without changing the separation itself.

Medtronic is in the final stage of separating its Diabetes business into MiniMed: it completed MiniMed’s IPO in March while retaining roughly 90% ownership, and launched the shareholder exchange offer on September 14, 2026 to complete the split-off.

This filing is a process correction, not a strategic update. Medtronic says the exchange offer began on September 14, 2026. 〔0〕 The only change is to the guaranteed-delivery deadline: holders using that procedure must deliver the remaining tender materials by 5:00 p.m. New York time on the second NYSE trading day after execution, rather than midnight.

The business story is unchanged. This does not alter the MiniMed separation, the number of shares offered, the ownership objective, or the exchange-offer economics described when the transaction launched. It simply removes ambiguity from how late tenders are completed; the direction and existence of the transaction were already public.

Bottom line: This is housekeeping around an already-announced separation, not a new signal about Medtronic or MiniMed. It matters operationally to shareholders using guaranteed delivery, but it does not change the investment case presented by the exchange offer itself.

What to watch next

Exchange offer expiration, October 9, 2026

Original filing on SEC EDGAR

More Medtronic plc news

Medtronic corrects MiniMed exchange-offer deadline, with no change to deal terms | MDT Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.